Apogee Therapeutics Shares Open For Trade At $21.50/Share; IPO Priced At $17/Share
Portfolio Pulse from Benzinga Newsdesk
Apogee Therapeutics' shares have started trading at $21.50 per share, which is higher than its IPO price of $17 per share.
July 14, 2023 | 2:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Apogee Therapeutics' shares opened at a price higher than its IPO price, indicating strong initial market interest.
The opening price of Apogee Therapeutics' shares was higher than its IPO price, which typically indicates strong initial market interest. This could potentially lead to a short-term increase in the stock price due to the high demand.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100